Complete remission of sclerodermatous cutaneous graft-versus-host disease after low-dose interleukine-2 treatment.
M WeissA de MassonM RobinR Peffault de LatourM BagotG SociéJean-David BouazizPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)